GenMark releases new rapid respiratory infection panel test

By staff writers

June 29, 2020 -- GenMark Diagnostics has released a new rapid result, multiple-virus panel test that can identify more than 20 pathogens, including SARS-CoV-2.

The company's ePlex Respiratory Pathogen 2 (RP2) panel is now available in the U.S. for distribution and use. Earlier this month, GenMark requested an emergency use authorization for the panel with the U.S. Food and Drug Administration.

The panel can be used to test for SARS-CoV-2, as well as influenza, adenovirus, rhinovirus, and respiratory syncytial virus, and produces results in less than two hours, according to the firm.

BioIQ, P23 launch home saliva panel test for COVID-19, flu
BioIQ and P23 labs have partnered to create an at-home COVID-19 test that screens a single self-collected saliva sample for SARS-CoV-2, influenza A, influenza...
Blood test bolsters imaging for staging pancreatic cancer
A multianalyte blood test was useful for diagnosing and staging pancreatic ductal adenocarcinoma, adding information beyond what is available from imaging...
How hospitals can clamp down on pricey panel tests for GI bugs
Monitoring the use of expensive gastrointestinal pathogen panel (GIPP) diagnostic testing -- and intervening when such tests are not indicated -- saves...

Copyright © 2020

Last Updated eh 7/1/2020 12:38:23 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.